000 | 06709cam a2200529 i 4500 | ||
---|---|---|---|
003 | OCoLC | ||
005 | 20221102222840.0 | ||
008 | 170721s2018 paua b 001 0 eng d | ||
010 | _a 2017034933 | ||
011 | _aMARC Score : 10650(26100) : OK | ||
011 | _aDirect Search Result | ||
011 | _aField 008 : Dates in the 008: 2017, 2018 appear to be inconsistent with dates derived from the 264 field: 2017, | ||
011 | _aChanged OCLC from 1015654322 to 1021228276 | ||
020 | _a149634796X | ||
020 | _a9781496347961 | ||
035 | _a(OCoLC)1021228276 | ||
040 |
_aAU@ _beng _erda _cAU@ _dWSU _dOCLCO _dOCLCA _dCLE _dOCLCF _dATU |
||
050 | 0 | 0 |
_aRM262 _b.A27 2017 |
082 | 0 | 0 |
_a615.19 _223 |
099 | _a615.19 ABR | ||
245 | 0 | 0 |
_aAbrams' clinical drug therapy : _brationales for nursing practice / _c[edited by] Geralyn Frandsen, Sandra Smith Pennington. |
246 | 1 | _aClinical drug therapy | |
246 | 3 | 0 | _aRationales for nursing practice |
250 | _a11th edition. | ||
264 | 1 |
_aPhiladelphia : _bWolters Kluwer, _c[2018] |
|
264 | 4 | _c©2018 | |
300 |
_axix, 1224 pages : _billustrations ; _c28 cm |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_aunmediated _bn _2rdamedia |
||
338 |
_avolume _bnc _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aSection 4. Drugs Affecting Inflammation and Infection : -- Section 5. Drugs Affecting the Cardiovascular System : -- Section 6. Drugs Affecting the Respiratory System : -- Section 7. Drugs Affecting the Renal and Digestive Systems : -- Section 8. Drugs Affecting the Endocrine System : -- Section 9. Drugs Affecting the Autonomic and Central Nervous System : -- Section 10. Drugs Affecting the Eye, Ear, and Skin : -- -- | |
505 | 0 | 0 |
_g1. _tThe Conceptual Framework of Pharmacology -- _g1. _tIntroduction to Pharmacology -- _g2. _tBasic Concepts and Processes -- _g3. _tMedication Administration and the Nursing Process of Drug Therapy -- _g2. _tDrug Therapy Throughout the Lifespan -- _g4. _tPharmacology and the Care of Infants and Pediatric Patients -- _g5. _tPharmacology and the Care of Adults and Geriatric Patients -- _g6. _tPharmacology and Care of Pregnant or Lactating Women -- _g7. _tPharmacology and Women's Health -- _g8. _tPharmacology and Men's Health -- _g3. _tDrugs Affecting the Hematopoietic and Immune Systems -- _g9. _tDrug Therapy for Coagulation Disorders -- _g10. _tDrug Therapy for Dyslipidemia -- _g11. _tDrug Therapy for Hematopoietic Disorders and to Enhance Immunity -- _g12. _tDrug Therapy: Immunizations -- _g13. _tDrug Therapy to Decrease Immunity -- _g14. _tDrug Therapy for the Treatment of Cancer -- _gSection 4. _tDrugs Affecting Inflammation and Infection : -- _g15. _tInflammation, Infection, and the Use of Antimicrobial Agents -- _g16. _tDrug Therapy to Decrease Pain, Fever, and Inflammation -- _g17. _tDrug Therapy with Corticosteroids -- _g18. _tDrug Therapy with Beta-Lactam Antibacterial Agents -- _g19. _tDrug Therapy with Aminoglycosides and Fluoroquinolones -- _g20. _tDrug Therapy with Tetracyclines, Sulfonamides, and Urinary Antiseptics -- _g21. _tDrug Therapy with Macrolides, Ketolides, and Miscellaneous Antibacterial Agents -- _g22. _tDrug Therapy for Tuberculosis and Mycobacterium avium Complex Disease -- _g23. _tDrug Therapy for Viral Infections -- _g24. _tDrug Therapy for Fungal Infections -- _g25. _tDrug Therapy for Parasitic Infections -- _gSection 5. _tDrugs Affecting the Cardiovascular System : -- _g26. _tDrug Therapy for Hypertension -- _g27. _tDrug Therapy for Dysrhythmias -- _g28. _tDrug Therapy for Coronary Heart Disease -- _g29. _tDrug Therapy for Shock and Hypertension -- _g30. _tDrug Therapy for Heart Failure -- _gSection 6. _tDrugs Affecting the Respiratory System : -- _g31. _tDrug Therapy for Nasal Congestion and Cough -- _g32. _tDrug Therapy to Decrease Histamine Effects and Allergic Response -- _g33. _tDrug Therapy for Asthma and Bronchoconstriction -- |
505 | 0 | 0 |
_gSection 7. _tDrugs Affecting the Renal and Digestive Systems : -- _g34. _tDrug Therapy for Fluid Volume Excess -- _g35. _tNutritional Support Products, Vitamins, and Mineral Supplements -- _g36. _tDrug Therapy for Weight Management -- _g37. _tDrug Therapy for Peptic Ulcer Disease and Hyperacidity -- _g38. _tDrug Therapy for Nausea and Vomiting -- _g39. _tDrug Therapy for Constipation and Elimination Problems -- _g40. _tDrug Therapy for Diarrhea -- _gSection 8. _tDrugs Affecting the Endocrine System : -- _g41. _tDrug Therapy for Diabetes Mellitus -- _g42. _tDrug Therapy for Hyperthyroidism and Hypothyroidism -- _g43. _tDrug Therapy for Pituitary and Hypothalamic Dysfunction -- _g44. _tDrug Therapy to Regulate Calcium and Bone Metabolism -- _g45. _tDrug Therapy for Addison's Disease and Cushing's Disease -- _gSection 9. _tDrugs Affecting the Autonomic and Central Nervous System : -- _g46. _tPhysiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy -- _g47. _tDrug Therapy for Myasthenia Gravis, Alzheimer's Disease and Urinary Retention -- _g48. _tDrug Therapy for Parkinson's Disease, Urinary Spasticity, and Disorders Requiring and Anticholinergic Drug Therapy -- _g49. _tDrug Therapy with Opioids -- _g50. _tDrug Therapy with Local Anesthetics -- _g51. _tDrug Therapy with General Anesthetics -- _g52. _tDrug Therapy for Migraines and Other Headaches -- _g53. _tDrug Therapy for Seizure Disorders and Spasticity -- _g54. _tDrug Therapy to Reduce Anxiety and Insomnia -- _g55. _tDrug Therapy for Depression and Mood Stabilization -- _g56. _tDrug Therapy for Psychotic Disorders -- _g57. _tDrug Therapy for Attention Defecit Hyperactivity Disorder and Narcolepsy -- _g58. _tDrug Therapy for Substance Abuse Disorders -- _gSection 10. _tDrugs Affecting the Eye, Ear, and Skin : -- _g58. _tDrug Therapy for Disorders of the Eye -- _g59. _tDrug Therapy for Disorders of the Ear -- _g60. _tDrug Therapy for Disorders of the Skin -- _gAppendix A. _tAnswers for NCLEX Success -- _gAppendix B. _tAnswers to Clinical Application Case Studies -- _gAppendix C. _tAnswers to Critical Thinking Questions -- _gAppendix D. _tThe International System of Units -- _gAppendix E. _tSerum Drug Concentrations. -- _gAppendix F. _tNormal Laboratory Values (SI and Traditional Units). |
650 | 0 |
_aChemotherapy. _9315208 |
|
650 | 0 |
_aDrugs. _9316861 |
|
650 | 0 |
_aNursing. _9321532 |
|
650 | 2 |
_aPharmaceutical Preparations _9513764 |
|
650 | 2 |
_aDrug Therapy. _9514399 |
|
650 | 2 |
_aPharmacological Phenomena. _9362168 |
|
700 | 1 |
_aFrandsen, Geralyn, _eeditor. _9834899 |
|
700 | 1 |
_aPennington, Sandra Smith, _eeditor. _9277456 |
|
907 |
_a.b24692955 _b06-09-21 _c24-01-18 |
||
942 | _cB | ||
945 |
_a615.19 ABR _g1 _iA554093B _j0 _lnmain _o- _p$155.51 _q- _r- _s- _t0 _u1 _v0 _w0 _x1 _y.i13593869 _z26-02-18 |
||
998 |
_a(2)b _a(2)n _b26-01-18 _cm _da _feng _gpau _h0 |
||
999 |
_c1449158 _d1449158 |